Ritonavir

Product NDC

68382-696

11-digit product format

683820696

Labeler code

68382

Product ID

68382-696_415d6153-5ad1-0b15-e631-937279e5838c

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

Ritonavir

Dosage form

TABLET, FILM COATED

Route

ORAL

Labeler

Zydus Pharmaceuticals USA Inc

Application

NDA022417

Marketing category

NDA AUTHORIZED GENERIC

Marketing start

2018-03-20

Marketing end

0000-00-00

Substance

RITONAVIR

Active strength

100 mg/1

Pharmacologic classes

HIV Protease Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],UDP Glucuronosyltransferases Inducers [MoA]

NDC exclude flag

No

Listing certified through

2020-12-31

Current FDA listing

Historical FDA.report record